Breakthrough invasive fungal infection in patients with myeloid malignancy receiving posaconazole tablet prophylaxis: Clinical features, risk factors, and posaconazole profiles. Medical Mycology, 2023, 61.5: myad046.
Risk factors for coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis in critically ill patients: a nationwide, multicenter, retrospective cohort study. Journal of Korean Medical Science, 2022, 37.18.
Severity-adjusted dexamethasone dosing and tocilizumab combination for severe COVID-19. Yonsei Medical Journal, 2022, 63.5: 430.